Literature DB >> 12653843

Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment.

M Engstrand1, A K Lidehall, T H Totterman, B Herrman, B-M Eriksson, O Korsgren.   

Abstract

The availability of tetrameric complexes of HLA class I molecules folded with immunodominant peptides makes it possible to utilize flow cytometry for rapid and highly specific visualization of virus specific CD8+ T cells. An alternate technique is to incubate whole blood with specific antigens and to subsequently detect and characterize responding T cells (e.g. by performing intracellular staining of interferon-gamma). By using an HLA-A2 tetramer construct folded with the same immunodominant CMV-peptide as that used for peptide pulsing, we monitored both the presence and functional capacity of CMV-specific CD8+ T cells. In addition T cell activation was assayed by determination of CD38 and CD69 expression. Twelve organ transplant patients and 31 healthy blood donors with latent CMV infection were investigated using CMV pp65 tetramer staining and intracellular staining of interferon-gamma after CMV pp65 peptide pulsing or CMV lysate pulsing. CMV-specific T cells were detected in similar absolute numbers as well as frequencies of T cells in the two groups investigated. However, the CMV-specific CD8+ T cells in immunosuppressed individuals showed a decreased functional response to the CMV-peptide, as evidenced by reduced interferon-gamma production when compared to healthy blood donors (19%; 42%, P < 0.005). In addition, CD38 expression was markedly higher in immunosuppressed patients compared to healthy blood donors (24%; 6%, P < 0.005). In a case report we demonstrate that reactivation of CMV can occur in an immunosuppressed patient with high number of CMV-specific T cells, but without functional capacity. Hence, these findings reflect impaired activation of cytotoxic T cells controlling latent CMV infection in immunosuppressed patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653843      PMCID: PMC1808671          DOI: 10.1046/j.1365-2249.2003.02098.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  Sequence-based typing provides a new look at HLA-C diversity.

Authors:  S Turner; M E Ellexson; H D Hickman; D A Sidebottom; M Fernández-Viña; D L Confer; W H Hildebrand
Journal:  J Immunol       Date:  1998-08-01       Impact factor: 5.422

2.  Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1.

Authors:  K V Komanduri; M N Viswanathan; E D Wieder; D K Schmidt; B M Bredt; M A Jacobson; J M McCune
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

3.  Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.

Authors:  S L Waldrop; C J Pitcher; D M Peterson; V C Maino; L J Picker
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

4.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

Authors:  M R Wills; A J Carmichael; K Mynard; X Jin; M P Weekes; B Plachter; J G Sissons
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Monitoring of cytomegalovirus infections by the CD8+CD38+ T-cell subset in kidney transplant recipients.

Authors:  M Belles-Isles; I Houde; J G Lachance; R Noël; I Kingma; R Roy
Journal:  Transplantation       Date:  1998-01-27       Impact factor: 4.939

6.  Optimization of whole blood antigen-specific cytokine assays for CD4(+) T cells.

Authors:  L E Nomura; J M Walker; H T Maecker
Journal:  Cytometry       Date:  2000-05-01

Review 7.  Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.

Authors:  B Fulton; A Markham
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

8.  Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.

Authors:  M Toyoda; J B Carlos; O A Galera; K Galfayan; X Zhang; Z Sun; L S Czer; S C Jordan
Journal:  Transplantation       Date:  1997-04-15       Impact factor: 4.939

9.  Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis.

Authors:  C R Li; P D Greenberg; M J Gilbert; J M Goodrich; S R Riddell
Journal:  Blood       Date:  1994-04-01       Impact factor: 22.113

10.  Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.

Authors:  M F Callan; L Tan; N Annels; G S Ogg; J D Wilson; C A O'Callaghan; N Steven; A J McMichael; A B Rickinson
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

View more
  13 in total

1.  Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses.

Authors:  Raskit Lachmann; Martha Bajwa; Serena Vita; Helen Smith; Elizabeth Cheek; Arne Akbar; Florian Kern
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Measurement of cytotoxic T lymphocyte activity of human cytomegalovirus seropositive individuals by a highly sensitive coupled luminescent method.

Authors:  Henry Ogbomo; Janina Geiler; Anke Leutz; Kristina von Kietzell; Martin Michaelis; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2009-10-08       Impact factor: 3.402

3.  Simultaneous monitoring of cytomegalovirus-specific antibody and T-cell levels in seropositive heart transplant recipients.

Authors:  Javier Carbone; Nallibe Lanio; Antonio Gallego; Florian Kern; Joaquin Navarro; Patricia Muñoz; Roberto Alonso; Pilar Catalán; Juan Fernández-Yáñez; Jesús Palomo; Manuel Ruiz; Eduardo Fernández-Cruz; Elizabeth Sarmiento
Journal:  J Clin Immunol       Date:  2012-02-29       Impact factor: 8.317

4.  T cell control of primary and latent cytomegalovirus infections in healthy subjects.

Authors:  Anna K Lidehall; Fredrik Sund; Tobias Lundberg; Britt-Marie Eriksson; Thomas H Tötterman; Olle Korsgren
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

5.  Single-cell T-cell receptor-β analysis of HLA-A*2402-restricted CMV- pp65-specific cytotoxic T-cells in allogeneic hematopoietic SCT.

Authors:  H Nakasone; Y Tanaka; R Yamazaki; K Terasako; M Sato; K Sakamoto; R Yamasaki; H Wada; Y Ishihara; K Kawamura; T Machishima; M Ashizawa; S-I Kimura; M Kikuchi; A Tanihara; J Kanda; S Kako; J Nishida; Y Kanda
Journal:  Bone Marrow Transplant       Date:  2013-08-12       Impact factor: 5.483

6.  BY55/CD160 cannot be considered a cytotoxic marker in cytomegalovirus-specific human CD8(+) T cells.

Authors:  J Merino; N Ramírez; C Moreno; E Toledo; M Fernández; A Sánchez-Ibarrola
Journal:  Clin Exp Immunol       Date:  2007-04-11       Impact factor: 4.330

7.  A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial.

Authors:  Thurid Ahlenstiel-Grunow; Armin Koch; Anika Großhennig; Cornelia Frömke; Martina Sester; Urban Sester; Christoph Schröder; Lars Pape
Journal:  Trials       Date:  2014-08-15       Impact factor: 2.279

8.  Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition.

Authors:  Aislin C Meehan; Nicole A Mifsud; Thi H O Nguyen; Bronwyn J Levvey; Greg I Snell; Tom C Kotsimbos; Glen P Westall
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

9.  Viral findings in adult hematological patients with neutropenia.

Authors:  Lars Ohrmalm; Michelle Wong; Carl Aust; Per Ljungman; Oscar Norbeck; Kristina Broliden; Thomas Tolfvenstam
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

Review 10.  Monitoring of pathogen-specific T-cell immune reconstitution after allogeneic hematopoietic stem cell transplantation.

Authors:  Shigeo Fuji; Markus Kapp; Hermann Einsele
Journal:  Front Immunol       Date:  2013-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.